Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®)

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/jir/volume-2019/2754920/figures/2754920.fig.005a.svgz" name="2754920.fig.005a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Mouse</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/jir/volume-2019/2754920/figures/2754920.fig.005b.svgz" name="2754920.fig.005b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Rabbit</td></tr></table>

<div>Antibody responses in mouse and rabbit sera against different antigens. Different antigens were used for the sensitization step in an indirect ELISA (TCRP-KLH, TCRP-BSA, KLH, and BSA) at 0.25 <i>μ</i>g/mL. (a) A pool of mice sera was diluted 1 : 1,000. (b) Serum from rabbit was diluted 1 : 25,000. ND: nondetected. Technical duplicates were carried out.</div>

Journal of Immunology Research

fig5

Figure 5

Figure 5: Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®) 